Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Qidong, China, 1992-2000 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total included	Dead		Alive		Complete FU		Median FU (in months)
Site	ICD-10	Total included	No.	%	No.	%	No.	%	Median FU (in months)
C03-06	Oral cavity	35	22	62.9	13	37.1	35	100.0	6.1
C11	Nasopharynx	164	106	64.6	58	35.4	164	100.0	8.2
C15	Oesophagus	942	871	92.5	71	7.5	942	100.0	3.6
C16	Stomach	3254	2625	80.7	629	19.3	3254	100.0	4.5
C17	Small intestine	35	29	82.9	6	17.1	35	100.0	4.3
C18	Colon	315	184	58.4	131	41.6	315	100.0	7.4
C19-20	Rectum	1010	696	68.9	314	31.1	1010	100.0	7.8
C22	Liver	7090	6424	90.6	666	9.4	7090	100.0	2.7
C23-24	Gall bladder	100	87	87.0	13	13.0	100	100.0	2.8
C25	Pancreas	661	595	90.0	66	10.0	661	100.0	2.8
C30-31	Nose/Sinuses	45	30	66.7	15	33.3	45	100.0	14.6
C32	Larynx	47	26	55.3	21	44.7	47	100.0	10.7
C33-34	Lung	3281	2940	89.6	341	10.4	3281	100.0	3.4
C37-38	Other thoracic organs	38	32	84.2	6	15.8	38	100.0	4.9
C40-41	Bone	149	126	84.6	23	15.4	149	100.0	4.3
C43	Melanoma skin	36	27	75.0	9	25.0	36	100.0	9.4
C44	Other skin	120	89	74.2	31	25.8	120	100.0	7.2
C47+C49	Connective tissue	32	21	65.6	11	34.4	32	100.0	9.8
C50	Breast	651	239	36.7	412	63.3	651	100.0	25.5
C53	Cervix	144	86	59.7	58	40.3	144	100.0	7.9
C54	Corpus uteri	69	27	39.1	42	60.9	69	100.0	21.1
C55	Uterus unspecified	41	25	61.0	16	39.0	41	100.0	8.1
C56	Ovary	101	61	60.4	40	39.6	101	100.0	9.7
C61	Prostate	55	39	70.9	16	29.1	55	100.0	5.3
C64	Kidney	72	50	69.4	22	30.6	72	100.0	3.8
C67	Urinary bladder	366	222	60.7	144	39.3	366	100.0	9.1
C70-72	Brain & nervous system	413	357	86.4	56	13.6	413	100.0	3.0
C73	Thyroid	48	12	25.0	36	75.0	48	100.0	20.3
C82-85+C96	Non-Hodgkin lymphoma	312	259	83.0	53	17.0	312	100.0	4.8
C90	Multiple myeloma	137	118	86.1	19	13.9	137	100.0	3.3
C91	Lymphoid leukaemia	81	70	86.4	11	13.6	81	100.0	2.4
C92-94	Myeloid leukaemia	216	197	91.2	19	8.8	216	100.0	2.4
C95	Leukaemia unspecified	107	99	92.5	8	7.5	107	100.0	3.6

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Qidong, China, 1992-2000 cases followed-up until 2000)
- Table5:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1991 and 1992-2000 (Qidong, China)
- Table6b:	Number of cases by cancer site and calendar period (Qidong, China, 1977-2000)
- Table7:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Qidong, China, 1977-2000 cases followed-up until 2000)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)